282 related articles for article (PubMed ID: 17594387)
1. Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes.
Charbonnel B
Int J Clin Pract Suppl; 2007 Jun; (153):1-2. PubMed ID: 17594387
[No Abstract] [Full Text] [Related]
2. Treating type 2 diabetes: targeting the many causative factors.
Sutherland JE; Hoehns JD
J Fam Pract; 2004 May; 53(5):376-88. PubMed ID: 15125823
[No Abstract] [Full Text] [Related]
3. Pioglitazone with sulfonylurea: glycemic and lipid effects in Taiwanese type 2 diabetic patients.
Tseng CH; Huang TS
Diabetes Res Clin Pract; 2005 Nov; 70(2):193-4. PubMed ID: 16188579
[No Abstract] [Full Text] [Related]
4. Which oral drug is right for your type 2 diabetes? New thinking on oral drug combinations that can provide better glycemic control.
Health News; 2005 Feb; 11(2):10-1. PubMed ID: 15732153
[No Abstract] [Full Text] [Related]
5. Insulin initiation in Type 2 diabetes.
Page S
Diabet Med; 2005 Sep; 22 Suppl 4():2-5. PubMed ID: 16109011
[No Abstract] [Full Text] [Related]
6. [Knack of treatment with oral hypoglycemic drugs in the elderly].
Komatsu M; Hashizume K
Nihon Rinsho; 2006 Jan; 64(1):93-8. PubMed ID: 16408454
[TBL] [Abstract][Full Text] [Related]
7. Management of type 2 diabetes mellitus. Role of thiazolidinediones.
Noble J; Baerlocher MO; Silverberg J
Can Fam Physician; 2005 May; 51(5):683-7. PubMed ID: 15934272
[TBL] [Abstract][Full Text] [Related]
8. [Combined insulin and sulfonylurea treatment in diabetes mellitus].
Ravina A; Minuhin O
Harefuah; 1986 Jan; 110(1):11-4. PubMed ID: 3514394
[No Abstract] [Full Text] [Related]
9. Oral agent therapy in the treatment of type 2 diabetes.
Feinglos MN; Bethel MA
Diabetes Care; 1999 Apr; 22 Suppl 3():C61-4. PubMed ID: 10189564
[No Abstract] [Full Text] [Related]
10. Beyond sulfonylureas: new oral medications in the treatment of NIDDM (type II DM).
Capriotti T
Medsurg Nurs; 1997 Jun; 6(3):166-9. PubMed ID: 9238992
[No Abstract] [Full Text] [Related]
11. Pharmacological treatment of type 2 diabetes.
Hermans MP; Buysschaert M
Acta Clin Belg; 2004; 59(2):59-66. PubMed ID: 15224468
[No Abstract] [Full Text] [Related]
12. [40 years of using sulfonylurea derivatives for treatment of diabetes].
Sieradzki J
Przegl Lek; 1996; 53(9):641-6. PubMed ID: 8992529
[TBL] [Abstract][Full Text] [Related]
13. [Warning signals insulin resistance. Insulin resistance causes not only diabetes].
MMW Fortschr Med; 2004 Jul; 146(29-30):49. PubMed ID: 15540564
[No Abstract] [Full Text] [Related]
14. Diabetes care: what should we try to achieve?
O'Connor PJ
J Fam Pract; 1991 Oct; 33(4):343-4. PubMed ID: 1919448
[No Abstract] [Full Text] [Related]
15. A miracle of salamization: positive divided by two equals negative.
Iwamoto Y
Diabet Med; 1997 Nov; 14(11):994. PubMed ID: 9400931
[No Abstract] [Full Text] [Related]
16. [Update on new oral treatment for diabetes].
Awad J; Schindel B; Schindel Y
Harefuah; 2001 Jan; 140(1):36-9. PubMed ID: 11242897
[No Abstract] [Full Text] [Related]
17. Initial management of glycemia in type 2 diabetes.
Banarer S
N Engl J Med; 2003 Feb; 348(8):760-1; author reply 760-1. PubMed ID: 12594327
[No Abstract] [Full Text] [Related]
18. Failure of sulfonylureas in type 2 diabetes.
Yildiz BO; Gürlek A
Horm Metab Res; 1999 Apr; 31(4):293-4. PubMed ID: 10333089
[No Abstract] [Full Text] [Related]
19. Oral hypoglycemic agents as an alternative therapy for gestational diabetes.
Hod M; Shafrir E
Isr J Med Sci; 1995 Oct; 31(10):640-3. PubMed ID: 7591693
[No Abstract] [Full Text] [Related]
20. Insulin sensitizer affects lipids.
Health News; 2005 Jan; 11(1):2. PubMed ID: 15726701
[No Abstract] [Full Text] [Related]
[Next] [New Search]
